Combined carboplatin and cisplatin. Limited Prospects for Dose Intensification
- 15 June 1993
- Vol. 71 (12) , 4060-4066
- https://doi.org/10.1002/1097-0142(19930615)71:12<4060::aid-cncr2820711242>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The management of follicular lymphomaAnnals of Oncology, 1991
- Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 yearsAnnals of Oncology, 1991
- Follicular lymphoma: A model of lymphoid tumor progression in manAnnals of Oncology, 1991
- High‐Dose cisplatin treatment: Hearing loss and plasma concentrationsThe Laryngoscope, 1990
- Carboplatin is ototoxicCancer Chemotherapy and Pharmacology, 1990
- Cisplatin Combined With Carboplatin: A New Way of Intensification of Platinum Dose in the Treatment of Advanced Ovarian CancerJNCI Journal of the National Cancer Institute, 1990
- Carboplatin: current status and future prospectsCancer Treatment Reviews, 1988
- The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assayEuropean Journal of Cancer and Clinical Oncology, 1988
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- High dose cisplatin and high dose carboplatin in refractory ovarian cancerCancer Treatment Reviews, 1985